Azacitid Injection 100 mg/vial contains Azacitidine, a hypomethylating agent used in the treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and related bone marrow disorders. It works by modifying abnormal DNA methylation patterns, helping restore normal function to bone marrow cells. This injection is administered under strict medical supervision in hospital or oncology settings.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Azacitidine 100 mg per vial

Mechanism of Action

Azacitidine is incorporated into DNA and RNA of abnormal hematopoietic cells. It inhibits DNA methyltransferase enzymes, leading to hypomethylation of DNA. This reactivates suppressed genes involved in normal cell differentiation and apoptosis, thereby reducing the proliferation of abnormal blood cells and improving bone marrow function.

Indications

Azacitid Injection is indicated for:

• Myelodysplastic syndromes (MDS)
• Acute myeloid leukemia (AML) in elderly or unfit patients
• Chronic myelomonocytic leukemia (CMML)
• Intermediate to high-risk bone marrow failure syndromes
• Other hematologic malignancies as prescribed by a specialist

Dosage and Administration

• Administered via subcutaneous or intravenous injection
• Dosage is strictly individualized based on body surface area and treatment cycle
• Commonly given for 7 consecutive days in a 28-day cycle
• Must be prepared and administered by trained healthcare professionals
• Regular monitoring of blood counts is essential during therapy

Benefits

• Helps control abnormal bone marrow cell growth
• Improves blood cell production and counts
• May delay progression to acute leukemia
• Standard therapy for high-risk MDS patients
• Proven efficacy in improving survival and quality of life in selected patients

Possible Side Effects

Common side effects may include:

• Nausea and vomiting
• Fatigue
• Fever
• Injection site reactions
• Diarrhea or constipation

Serious side effects:

• Severe bone marrow suppression (low WBC, RBC, platelets)
• Increased risk of infections
• Bleeding complications
• Liver or kidney dysfunction
• Severe allergic reactions

Immediate medical attention is required for signs of infection or abnormal bleeding.

Precautions and Warnings

• Requires frequent complete blood count (CBC) monitoring
• Use cautiously in patients with liver or kidney impairment
• Increased risk of infections due to immunosuppression
• Not recommended during pregnancy or breastfeeding
• Should only be administered under oncology supervision

Drug Interactions

• May enhance bone marrow suppression when used with other cytotoxic drugs
• Caution with immunosuppressants
• Inform physician about all ongoing medications

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 25–30°C as per manufacturer guidance
• Protect from light and moisture
• Reconstituted solution should be used immediately or as directed
• Keep out of reach of children

Conclusion

Azacitid Injection 100 mg/vial (Azacitidine) is an essential hematology-oncology medication used for the treatment of myelodysplastic syndromes and certain leukemias. It works by restoring normal gene expression in abnormal blood cells, helping to control disease progression under careful specialist supervision.